Rheumatology
News
Greater myocardial inflammation found in RA patients after heart attack
Key clinical point:Post-MI autopsy data support the view that RA patients have greater intramyocardial inflammatory burden than do patients...
News
Biosimilar infliximab gains FDA Advisory Committee endorsement
Conference Coverage
End-stage renal disease risk in lupus nephritis remains unchanged of late
Key clinical point: The risk of end-stage renal disease in lupus nephritis decreased from the 1970s to the mid-1990s but has since remained...
News
Wearable device offers home-based knee OA pain relief
Key clinical point: Pulsed electromagnetic fields therapy is safe and effective in improving knee osteoarthritis symptoms. Major finding: The mean...
News
Simple SpA screening tool works in U.S. population
People under the age of 45 with chronic back pain for 3 or more months can be reliably identified as having axial SpA if they have one or more of...
News
Step therapy and biologics: An easier road ahead?
Payers’ fail-first policies pose special concerns for clinicians treating with biologic therapies. Until these become cheaper, navigating them...
News
MRI findings beyond sacroiliitis not necessary for classifying nonradiographic axial SpA
News
Secukinumab receives FDA approval for psoriatic arthritis, ankylosing spondylitis
Conference Coverage
ACR: Push back when insurance decisions force TNFi change
Stopping a tumor necrosis factor inhibitor for nonmedical reasons such as increased copays, change of insurance, or loss of job health insurance...
Conference Coverage
EADV: DLX105 is a novel treatment strategy for Behçet’s flares
DLX105, a highly potent single-chain antibody fragment, shows early promise as a fast-acting treatment of flares of Behçet’s disease.